Soligenix
SNGX
#10944
Rank
A$7.92 M
Marketcap
A$0.53
Share price
-3.72%
Change (1 day)
-85.72%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2026 (TTM): -A$17.47 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$16.79 Million a decrease over its 2024 earnings that were of -A$13.25 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$17.47 Million4.06%
2025 -A$16.79 Million26.72%
2024 -A$13.25 Million22.96%
2023 -A$10.77 Million-45.74%
2022 -A$19.85 Million11.88%
2021 -A$17.74 Million-32.37%
2020 -A$26.23 Million83.18%
2019 -A$14.32 Million11.57%
2018 -A$12.84 Million19.29%
2017 -A$10.76 Million33%
2016 -A$8.09 Million-19.7%
2015 -A$10.08 Million5.16%
2014 -A$9.58 Million
2010 -A$10.82 Million26.12%
2009 -A$8.58 Million75.1%
2008 -A$4.9 Million-45.38%
2007 -A$8.97 Million-22.84%
2006 -A$11.62 Million66.15%
2005 -A$7 Million-16.65%
2004 -A$8.39 Million13.28%
2003 -A$7.41 Million-11.88%
2002 -A$8.41 Million-59.44%
2001 -A$20.72 Million378.18%
2000 -A$4.34 Million-38.53%
1999 -A$7.05 Million-18.43%
1998 -A$8.65 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.80 B-222,070.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$15.00 B-90,591.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.84 B-65,535.84%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-A$25.72 Million 55.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-A$59.17 Million 256.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.21 B-19,503.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-A$3.9 Million-76.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$83.72 M-604.96%๐Ÿ‡บ๐Ÿ‡ธ USA